Sponsor:
Mayo Clinic
Code:
NCT05285566
Conditions
Nasal Surgery
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Exparel
Xylocaine
Brief summary:
Conditions
Nasal Surgery
Study ID
NCT05285566
Start date
May 4, 2022
Status verified date
Sep, 2025
Completion date
Sep, 2026
Anticipated
Primary completion date
Aug, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
60 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Exparel® Injection Group
active comparator: Xylocaine® Injection Group
Interventions
Exparel
Xylocaine
Primary outcome measure
Central contacts
Locations
Mayo Clinic in Rochester
Recruiting
Rochester, Minnesota, United States, 55905
Contacts
Dan Osland
osland.daniel@mayo.eduSponsor
Mayo Clinic
Last update posted
Sep 12, 2025
Last verified
Sep, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2025-09-12.